Search Results Label

Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.seqirus.us/expertise

Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.

https://www.seqirus.us/our-company/leadership

Our leadership team is composed of experienced professionals with deep scientific expertise and a shared commitment to public health. Meet them now.

https://www.seqirus.us/our-company/leadership/gregg-sylvester

Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.

https://www.seqirus.us/our-company

Seqirus will develop and evaluate two influenza A(H2Nx) virus vaccine candidates in support of U.S. government pandemic preparedness objectives

https://www.seqirus.us/news/seqirus-awarded-us-government-contract-for-two-influenza-vaccines

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate

https://www.seqirus.us/news/the-university-of-queensland-cepi-and-csl-partner-on-covid-19-vaccine-candidate

Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.

https://www.seqirus.us/news/covid19-update

Afluria QIV is produced by Seqirus Inc., a company with specific expertise in influenza vaccines.

https://www.seqirus.us/-/media/seqirus/pdfs/pregnancy-registry-documents/afluria-informed-consentv10sample.pdf

Seqirus is first-to-market with shipment of seasonal influenza vaccines to the US for the 2016-2017 season

https://www.seqirus.us/news/seqirus-is-first-to-market-with-shipment-of-seasonal-influenza-vaccines-for-2016-2017-season

About Seqirus Seqirus is the new global company created in July 2015 from the combined strength and expertise of bioCSL Inc. and the influenza vaccines business formerly owned by Novartis AG.

https://www.seqirus.us/-/media/seqirus-us/news/franchise-shipment-press-release--71116final-530-pm.pdf